Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 11.47%16.18M | 17.52%29.57M | 17.31%14.51M | -4.72%25.16M | -10.64%12.37M | 9.79%26.41M | 17.42%13.85M | 12.12%24.05M | 9.30%11.79M | -11.59%21.45M |
| Operating income | 11.47%16.18M | 17.52%29.57M | 17.31%14.51M | -4.72%25.16M | -10.64%12.37M | 9.79%26.41M | 17.42%13.85M | 12.12%24.05M | 9.30%11.79M | -11.59%21.45M |
| Cost of sales | -12.60%-5.97M | -13.89%-10.88M | -11.13%-5.3M | 7.11%-9.56M | 13.26%-4.77M | -14.44%-10.29M | -31.40%-5.5M | -8.30%-8.99M | -8.20%-4.19M | 6.60%-8.3M |
| Operating expenses | -12.60%-5.97M | -13.89%-10.88M | -11.13%-5.3M | 7.11%-9.56M | 13.26%-4.77M | -14.44%-10.29M | -31.40%-5.5M | -8.30%-8.99M | -8.20%-4.19M | 6.60%-8.3M |
| Gross profit | 10.82%10.21M | 19.75%18.68M | 21.19%9.21M | -3.18%15.6M | -8.91%7.6M | 7.01%16.12M | 9.73%8.35M | 14.53%15.06M | 9.91%7.61M | -14.47%13.15M |
| Selling expenses | -21.94%-5.42M | -36.71%-9.21M | -39.75%-4.44M | -0.43%-6.74M | 2.75%-3.18M | -9.85%-6.71M | -14.14%-3.27M | -13.44%-6.11M | -5.72%-2.87M | -15.48%-5.39M |
| Administrative expenses | -24.90%-5.55M | -9.97%-10.08M | -10.62%-4.45M | -19.93%-9.17M | -18.45%-4.02M | -12.00%-7.65M | -2.14%-3.39M | 2.75%-6.83M | -2.63%-3.32M | 0.28%-7.02M |
| Special items of operating profit | 49.18%91K | 8.05%443K | -66.11%61K | -31.44%410K | -64.50%180K | -60.27%598K | -43.23%507K | 34.02%1.51M | 29.80%893K | -0.97%1.12M |
| Operating profit | -274.74%-671K | -266.02%-171K | -34.13%384K | -95.63%103K | -73.38%583K | -35.05%2.36M | -5.28%2.19M | 94.38%3.63M | 39.19%2.31M | -61.14%1.87M |
| Financing income | ---- | -61.79%47K | ---- | 296.77%123K | 360.87%60K | 127.68%31K | 54.90%-23K | ---112K | ---51K | ---- |
| Financing cost | -452.50%-141K | ---- | --40K | ---- | ---- | ---- | ---- | ---- | ---- | -36.36%-60K |
| Earning before tax | -291.51%-812K | -154.87%-124K | -34.06%424K | -90.54%226K | -70.33%643K | -32.10%2.39M | -4.16%2.17M | 94.63%3.52M | 35.07%2.26M | -62.04%1.81M |
| Tax | -2.30%-222K | -680.43%-359K | -9.60%-217K | 91.56%-46K | 49.23%-198K | 20.90%-545K | 31.10%-390K | 10.40%-689K | -28.05%-566K | 36.08%-769K |
| After-tax profit from continuing operations | -599.52%-1.03M | -368.33%-483K | -53.48%207K | -90.23%180K | -74.96%445K | -34.83%1.84M | 4.84%1.78M | 172.45%2.83M | 37.58%1.7M | -70.82%1.04M |
| Earning after tax | -599.52%-1.03M | -368.33%-483K | -53.48%207K | -90.23%180K | -74.96%445K | -34.83%1.84M | 4.84%1.78M | 172.45%2.83M | 37.58%1.7M | -70.82%1.04M |
| Profit attributable to shareholders | -599.52%-1.03M | -368.33%-483K | -53.48%207K | -90.23%180K | -74.96%445K | -34.83%1.84M | 4.84%1.78M | 172.45%2.83M | 37.58%1.7M | -70.82%1.04M |
| Basic earnings per share | -250.00%-0.0012 | -400.00%-0.0006 | 100.00%0.0008 | -90.00%0.0002 | -80.95%0.0004 | -50.00%0.002 | 0.00%0.0021 | 300.00%0.004 | 40.00%0.0021 | -80.00%0.001 |
| Diluted earnings per share | -250.00%-0.0012 | -400.00%-0.0006 | 100.00%0.0008 | -90.00%0.0002 | -80.95%0.0004 | -50.00%0.002 | 0.00%0.0021 | 300.00%0.004 | 40.00%0.0021 | -80.00%0.001 |
| Currency Unit | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Forvis Mazars LLP | -- | Forvis Mazars LLP | -- | Mazars LLP | -- | Mazars LLP | -- | Mazars LLP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.